These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 447032

  • 1. Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog.
    Corazziari E, Solomon TE, Grossman MI.
    Gastroenterology; 1979 Jul; 77(1):91-5. PubMed ID: 447032
    [Abstract] [Full Text] [Related]

  • 2. Further studies on the effect of cholecystokinin and secretin on the content of cyclic AMP, cyclic GMP, protein and calcium in pure pancreatic juice of dogs.
    Singer MV, Cailla H.
    Z Gastroenterol; 1980 May; 18(5):265-73. PubMed ID: 6254284
    [Abstract] [Full Text] [Related]

  • 3. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [Abstract] [Full Text] [Related]

  • 4. Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man.
    Valenzuela JE, Walsh JH, Isenberg JI.
    Gastroenterology; 1976 Sep; 71(3):409-11. PubMed ID: 950091
    [Abstract] [Full Text] [Related]

  • 5. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

  • 6. The effects of ammonia on pancreatic enzyme secretion in vivo and in vitro.
    Jaworek J, Bilski J, Jachimczak B, Cieszkowski M, Kot M, Bielański W, Konturek SJ.
    J Physiol Pharmacol; 2000 Jun; 51(2):315-32. PubMed ID: 10898103
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of gastric emptying is a physiological action of cholecystokinin.
    Debas HT, Farooq O, Grossman MI.
    Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
    [Abstract] [Full Text] [Related]

  • 8. Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa.
    Johnson LR, Guthrie P.
    Gastroenterology; 1976 Jan; 70(1):59-65. PubMed ID: 1245285
    [Abstract] [Full Text] [Related]

  • 9. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
    You CH, Rominger JM, Chey WY.
    Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
    [Abstract] [Full Text] [Related]

  • 10. Secretin snuff: evaluation of the action on pentagastrin-stimulated gastric acid secretion and on pancreatic bicarbonate production.
    Halter F, Witzel L, Kohler B, Hadorn B.
    Scand J Gastroenterol; 1975 Jul; 10(1):81-5. PubMed ID: 1168364
    [Abstract] [Full Text] [Related]

  • 11. The influence of hypercalcemia on basal and cholecystokinin-stimulated pancreatic, gallbladder, and gastric functions in man.
    Malagelada JR, Holtermuller KH, Sizemore GW, Go VL.
    Gastroenterology; 1976 Sep; 71(3):405-8. PubMed ID: 950090
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic polypeptide and vagal stimulation of gastric and pancreatic secretion in dogs.
    Swierczek JS, Konturek SJ, Tasler J, Jaworek J, Cieszkowski M.
    Hepatogastroenterology; 1981 Aug; 28(4):206-9. PubMed ID: 6792020
    [Abstract] [Full Text] [Related]

  • 13. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
    Schmidt WE, Schenk S, Nustede R, Holst JJ, Fölsch UR, Creutzfeldt W.
    Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
    [Abstract] [Full Text] [Related]

  • 14. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog.
    Meyer FD, Gyr K, Häcki WH, Beglinger C, Jeker L, Varga L, Kayasseh L, Gillessen D, Stalder GA.
    Gastroenterology; 1981 Apr; 80(4):742-7. PubMed ID: 7202946
    [Abstract] [Full Text] [Related]

  • 15. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A, Warzecha Z, Konturek SJ, Cai RZ, Schally AV.
    J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of neurotensin, secretin and cholecystokinin on pancreatic exocrine secretion in conscious dogs.
    Sakamoto T, Fujimura M, Townsend CM, Greeley GH, Thompson JC.
    Surg Gynecol Obstet; 1988 Jan; 166(1):11-6. PubMed ID: 3336811
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H.
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.